Distek, Inc. launches revolutionary benchtop scale bioreactor

NewsGuard 100/100 Score

From the company that has brought you over 40 years of excellence in laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne 1250 Bioprocess Control Station.

BIOne Controller with Glass Bioreactor.

Distek, Inc. has revolutionized benchtop scale bioreactors with the release of our BIOne 1250 bioprocess control station for both mammalian and microbial models. The sleek appearance and intuitive touchscreen interface are only the beginning. The BIOne controller can seamlessly transition between traditional glass reactors and our BIOne single-use system.

Our expansion into the biotech arena marks another major milestone in Distek’s longstanding company history.  The BIOne 1250 offers an innovative approach to greatly assist our biotech customers.”

Jeff Brinker, President of Distek

Easy to use, the BIOne bioprocess control station is powerful enough to develop processes at the benchtop scale. Designed to fit your needs, the BIOne controller can be customized to conform to your lab design...rotameters or auto flow control, left or right-side setup, optical pH or standard, smart sensors or standard sensors and much more.

The release of the BIOne 1250 controller will establish Distek as an innovator in the benchtop bioreactor space and quickly establish Distek as a key player.”

Jeff Seely, Vice President of Sales & Business Development, Distek, Inc

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ketone supplement boosts efficacy of prostate cancer immunotherapy